917
[Otitis media aguda. Diagnóstico y manejo práctico - Dr. Francisco J. Krause]
País/región
Edad
N
% de bacterias responsables
Ref.
Hi
Spn
Mcat
Sud américa
Argentina (1990–1992)
1m—11y
161
13.7%
20.5%
1.2%
[27]
Argentina (1996–1997)
15d—24m 367
24.5%
27.8%
0.5%
[28]
Brasil (1990–1995)
2m—5y
300
7.0%
16.0%
5.0%
[29]
Chile (1998–1999)
3m—9y
170
24.1% 37.1%
1.2%
[30]
Chile (1998–2002)
3m—9y
543
28.7% 39.8%
4.2%
[31]
Costa Rica (1992–1997)
4m—12y
398
14.1%
29.6%
1.5%
[32]
Costa Rica (1999–2001)
4m—12y
102
13.7%
42.2%
2.9%
[16]
Costa Rica (2002–2007)
2m—8y
880
23.0%
27.7%
8.8%
[17]
Colombia (1979–1985)
18d—11y
111
35.1%
23.4%
0.9%
[33]
Colombia (2008–2009)
3m—5y
83
28.9%
30.1%
ND
[34]
México (2008–2009)
3m—5y
99
31.3%
31.3%
2.0%
[35]
Venezuela (2008–2009)
3m—5y
82
41.5%
23.2%
1.2%
[36]
Promedio
23.8%
29.1%
2.7%
Max
41.5%
42.2%
8.8%
Min
7.0%
16.0%
0.5%
Norte América
US (1989–1993)
2m—7y
815
23.3%
24.9%
15.0%
[21]
US (1993–1995)
≤
6y (86%)
159
28.3%
38.4%
25.8%
[22]
US (1989–1998)
2m—7y
982
23.3%
25.8%
13.1%
[23]
US (2005–2009)
2m—3y
184
31.5%
30.4%
7.6%
[24]
US (2006–2008)
6m—3y
170
31.8%
20.6%
7.6%
[25]
US (2008–2010)
4m—3y
208
28.4%
31.7%
13.9%
[26]
Promedio
27.8%
28.6%
13.8%
Max
31.8%
38.4%
25.8%
Min
23.3%
20.6%
7.6%
Europa
España (1989–1995)
1m—14y
104
28.8%
34.6%
1.0%
[37]
Finlandia (1980–1985)
≤
3m
85
11.8%
18.8%
3.5%
[38]
Finlandia (1990–1992)
3m—8y
118
18.6%
22.0%
10.2%
[20]
Finlandia (1994–1995)
2m—2y
772
22.5%
26.0%
22.9%
[39]
Finlandia (1998–1999)
7m—6y
79
29.1%
49.4%
27.8%
[40]
Alemania
(2008–2010)
3m—5y
24
29.1%
ND
4.2%
[41]
Promedio
23.3%
30.2%
11.6%
Max
29.1%
49.4%
27.8%
Min
11.8%
18.8%
1.0%
Tabla 2. Bacteriología detectada en efusión de pacientes con OMA